SciELO - Scientific Electronic Library Online

 
vol.67 issue4Quality of life in patients with proliferative diabetic retinopathyWildervanck syndrome author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista Brasileira de Oftalmologia

Print version ISSN 0034-7280On-line version ISSN 1982-8551

Abstract

SIQUEIRA, Rubens Camargo; JORGE, Rodrigo  and  CANAMARY, Fabio. Intravenous sodium fluorescein enhances the visibility of vitreous during vitrectomy surgery for diabetic retinopathy. Rev. bras.oftalmol. [online]. 2008, vol.67, n.4, pp.184-187. ISSN 0034-7280.  http://dx.doi.org/10.1590/S0034-72802008000400005.

OBJECTIVE: To observe the effectiveness of intravenous sodium fluorescein visibility in the vitreous during vitrectomy surgery in patients with diabetic retinopathy. METHODS: Fourteen consecutive cases of vitreoretinal surgery for vitreous hemorrhage and tractional retinal detachment secondary to diabetic retinopathy underwent intravenous injection of sodium fluorescein to 20% 1 hour before the surgery. The images of the steps of the surgeries were recorded. RESULTS: The sodium fluorescein stained green from the vitreous peripheral, vitreous base, posterior hyaloid, further improving visibility to a complete and more secure vitrectomy. The sodium fluorescein also stained fibrous points (sites of neovascularization) with high intensity making it easier its visibility. No complications associated with the dye injection were observed in all cases. CONCLUSION: Intravenous sodium fluorescein can be used safely for facilitating the observation of the vitreous, vitreous base, posterior hyaloid and sites of neovascularization. This technique can facilitate the process of vitrectomy in patients with diabetic retinopathy.

Keywords : Fluorescein; Diabetic retinopathy; Vitrectomy.

        · abstract in Portuguese     · text in English     · English ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License